Date: Thu, 28 Mar 2024 19:49:00 +0100 (CET) Message-ID: <1211910713.2238.1711651740835@k5086.pixsoftware.de> Subject: Exported From Confluence MIME-Version: 1.0 Content-Type: multipart/related; boundary="----=_Part_2237_1191385705.1711651740834" ------=_Part_2237_1191385705.1711651740834 Content-Type: text/html; charset=UTF-8 Content-Transfer-Encoding: quoted-printable Content-Location: file:///C:/exported.html
These data are submitted by the = cord blood bank to the WMDA in February 2015. The WMDA makes no representat= ions or express or implied warranties regarding any information on this sit= e or obtained through these links; expressly disclaims all legal liability = and responsibility for the accuracy, completeness, currency, suitability, v= alidity, or usefulness of such information; and is not and will not be liab= le for any statements, errors, or omissions in posted information, or for a= ny losses, injuries, or damages that arise or are alleged to arise from suc= h information. Use of any information provided on this site does not and is= not intended to create a contractual or other relationship. All informatio= n is on an as-is basis. The data cannot be updated.
1. General Information | |
---|---|
Name of CBB | CBB Basel |
CBB Director | Dimitrios |
CBB Director | Tsakiris |
Address | Diagnostic Hematology |
Address | University Hospital Basel |
Address | Petersgraben 4 |
Address | CH-4031 |
Address | Basel |
Phone Number | +41612652525 |
Date CBB Started Collecting C=
ord Blood Units (month/day= /year) |
06/04/1997 |
Number of Public Cord Blood U= nits | 2,966 |
Planned Number of Public Cord= Blood Units Stored in 2015 | 150 |
Lists on BMDW | No |
Affiliated with National Stem= Cell Donor Registry | Yes |
Registry Affiliation | Swiss Blood Stem Cell Registry |
2. Cord Blood Units in Inventory | |
Current Processing Method | Liquid+ red auto |
Previous Processing Method= td> | Liquid- red manual |
Year Current Process Method = Started | 2000 |
Percent of Units Plasma and = RBC Reduced (manual) | 4 |
Percent of Units Plasma and = RBC Reduced (automated) | 96 |
3. Accreditations, Licenses and Certifications= th> | |
FACT-Netcord | No |
AABB | No |
Competent Authority/ Nationa= l Health Authority | Yes |
Name of Competent Authority<= /td> | BAG |
Audited by National Stem Cel= l Registry | Yes |
ISO | Yes |
Other | ISO17025 JACIE |
4. Cord Blood Collection | |
Current Collection Practice<= br>Is the collection In/Ex -U= tero or both? | Ex-utero |
Current Antiseptic | Betadine |
Collection Bag | Single needle |
Agitation during Collection<= /td> | Manual |
5. Conditioning/Transport from Collection Site t= o CBB | |
Secondary Bag Used | Yes |
Transport Conditions | Ground transport |
Temp. for Storage and Transp= ort | Temperature between +2 to +8=C2=B0C |
6. Pre-Processing Evaluation | |
Completed Prior to Accepting= a CBU | Medical history, collection report, informed con= sent |
External Proficiency Testing= for QC of FACS Lab | UKNEQAS |
Post Processing/ Pre Freeze = CD34+ Cell Count | Yes |
Time from Collection to Proc= essing | up to 48H |
7. Processing and Packaging | |
Pre Freeze Processing Method= s- Unit in Inventory | SEPAX |
Pre Freeze Processing Method= s- Unit in Inventory | Volume reduction with HES-Manual |
Pre Freeze Processing Method= s- Current | SEPAX |
Additives Currently in Use= td> | HES |
Current Cryopreservation Met= hod | BioArchive |
Current Cryoprotectant Addit= ive | DMSO |
Current Cryobag | Single bag (one fraction) |
Current Target Cryopreservat= ion Volume (mL) | 25.0 |
Current Packaging for Storag= e | Overwrap |
Current Packaging for Storag= e | Canister |
Current Packaging for Storag= e | More than one segment |
8. Testing | |
Extra Material Currently Sto= red | Cord blood DNA |
Extra Material Currently Sto= red | Plasma/cord blood |
Extra Material Currently Sto= red | Maternal DNA |
Extra Material Currently Sto= red | Maternal plasma/serum |
Current Post Processing Thre=
shold for Accepting a CBU for Public Use TNC |
150 |
Current Post Processing Thre=
shold for Accepting a CBU for Public Use CD34 (10^6) Single Platform |
NA |
Current Post Processing Thre=
shold for Accepting a CBU for Public Use CD34 (10^6) Double Platform |
NA |
Current Post Processing Thre=
shold for Accepting a CBU for Public Use CFU-GM |
NA |
Current Post Processing Thre=
shold for Accepting a CBU for Public Use CFU |
NA |
Current Post Processing Thre=
shold for Accepting a CBU for Public Use Viability |
NA |
9. Storage | |
Type of Storage Container Us= ed | BioArchive |
Monitoring of Storage | Centralized alarm system local |
Monitoring of Storage | Centralized system remote monitoring |
Monitoring of Storage | LN2 level |
10. HLA Typing | |
Current Level of HLA Typing =
at Time of Listing HLA-A <= /span> |
IR |
Current Level of HLA Typing =
at Time of Listing HLA-B <= /span> |
IR |
Current Level of HLA Typing =
at Time of Listing HLA-C <= /span> |
|
Current Level of HLA Typing =
at Time of Listing HLA-DRB= 1 |
IR |
Current Level of HLA Typing =
at Time of Listing HLA-DQB= 1 |
|
Current Level of HLA Typing =
at Time of Listing HLA-DPB= 1 |
|
Accreditation of HLA Lab | EFI accredited lab |
Average Turnaround Time for =
Extended HLA Typing Results in days |
7 |
Attached Segment Used for Co= nfirmatory/ Verification Typing | No |
Units Listed without Attache= d Segment and have not been Previously Typed on Attached Segment | No |
Percentage of CBUs that have= an Attached Segment | below 50% |
Confirmatory/ Verification T= yping on an Attached Segment is Pre-Release Requirement | No |
11. Reservation and Cancellation Policies | |
What Point is a CBU Reserved= for a Patient | HLA typing request |
What Point is a CBU Reserved= for a Patient | Reservation request |
Length of Time a CBU can be =
Reserved in days | Other |
Length of Time a CBU can be =
Reserved in days | not defined |
Reservation Fee | Yes |
Reservation Cancellation Fee= in Absence of Shipment Request | No |
Can Reservation be Extended<= /td> | Yes |
Is a Unit Report Provided on= a Unit that is Reserved for Another Patient | No |
Is TC Informed when CBU is R= eleased | Yes |
12. Release and Shipment | |
Hemoglobinopathy Screening P= erformed Prior to Release | Yes |
Criteria to Ship a CBU |
NA |
Criteria to Ship a CBU |
Yes |
Current Packaging for Shipme= nt to TC | Metal canister |
Current Packaging for Shipme= nt to TC | Overwrap |
Current Packaging for Shipme= nt to TC | 2 attached segments |
Time Between Shipment Reques= t and Sending CBU | 1-2 weeks |
Fee for Shipment Cancellatio= n | No |
Dry Shippers Validated to Ma= intain Temperature of at least -150 for 48 hours Beyond Expected Arrival | Yes |
Electronic Temperature Data = Logger on All Dry Shippers | Yes |
Who Selects Transport Compan= y | Requesting transplant centre |
Shape of Transport Container= | Mushroom |
13. Adverse Events Reporting | |
Who are S(P)EARS Reported To=
Competent Authority |
Yes |
Who are S(P)EARS Reported To=
National Registry = |
Yes |
Who are S(P)EARS Reported To=
Transplant Center<= /td> | Yes |